Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study
Background: Upper tract urothelial carcinoma (UTUC) is a rare malignancy, accounting for 5–10% of all urothelial carcinomas (UCs). Radical nephroureterectomy (RNU) has been the standard treatment, but kidney-sparing surgery (KSS) via ureteroscopy (URS) is now recommended for low-risk cases. KSS is a...
| Published in: | European Urology Open Science |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168325001065 |
| _version_ | 1849693976087494656 |
|---|---|
| author | Orlane Figaroa Ranan Dasgupta Nora Hendriks Guido Kamphuis Jorg Oddens Jeroen van Moorselaar Adriaan Bins Joyce Baard |
| author_facet | Orlane Figaroa Ranan Dasgupta Nora Hendriks Guido Kamphuis Jorg Oddens Jeroen van Moorselaar Adriaan Bins Joyce Baard |
| author_sort | Orlane Figaroa |
| collection | DOAJ |
| container_title | European Urology Open Science |
| description | Background: Upper tract urothelial carcinoma (UTUC) is a rare malignancy, accounting for 5–10% of all urothelial carcinomas (UCs). Radical nephroureterectomy (RNU) has been the standard treatment, but kidney-sparing surgery (KSS) via ureteroscopy (URS) is now recommended for low-risk cases. KSS is associated with a higher rate of intravesical recurrence (IVR). The SINCERE study is evaluating whether a single postoperative intravesical instillation of mitomycin C (SI-MMC) after URS can reduce the IVR rate. Study design: This is a prospective multicenter registry study enrolling patients with nonmetastatic UTUC undergoing URS followed by SI-MMC. Data will be compared to a historical control cohort without adjuvant MMC. Patients are aged ≥18 yr with no history of bladder cancer or contralateral UTUC. The study is following the principles of the Declaration of Helsinki and has received ethics approval. Primary and secondary outcomes: The primary outcome is total IVR and time to IVR. The secondary outcome is evaluation of predictive variables for IVR in patients with UTUC after endoscopic treatment. Discussion: Given the high recurrence rate after URS, the study aim is to provide evidence regarding MMC use to reduce IVR and address the current lack of robust data for this strategy. The study has potential to change clinical practice by demonstrating the efficacy of SI-MMC in preventing IVR after URS for UTUC. |
| format | Article |
| id | doaj-art-ce7c7cef13134ecebbc2d0a916bcfcc2 |
| institution | Directory of Open Access Journals |
| issn | 2666-1683 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Elsevier |
| record_format | Article |
| spelling | doaj-art-ce7c7cef13134ecebbc2d0a916bcfcc22025-08-20T02:06:27ZengElsevierEuropean Urology Open Science2666-16832025-06-0176172210.1016/j.euros.2025.03.017Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry StudyOrlane Figaroa0Ranan Dasgupta1Nora Hendriks2Guido Kamphuis3Jorg Oddens4Jeroen van Moorselaar5Adriaan Bins6Joyce Baard7Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands; Corresponding author. Department of Urology, Amsterdam UMC, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Tel. +31 20 5669111; Fax: +31 20 4446031.Department of Urology, Imperial College Healthcare NHS Trust, London, UKDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The NetherlandsDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The NetherlandsDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The NetherlandsDepartment of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The NetherlandsDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The NetherlandsBackground: Upper tract urothelial carcinoma (UTUC) is a rare malignancy, accounting for 5–10% of all urothelial carcinomas (UCs). Radical nephroureterectomy (RNU) has been the standard treatment, but kidney-sparing surgery (KSS) via ureteroscopy (URS) is now recommended for low-risk cases. KSS is associated with a higher rate of intravesical recurrence (IVR). The SINCERE study is evaluating whether a single postoperative intravesical instillation of mitomycin C (SI-MMC) after URS can reduce the IVR rate. Study design: This is a prospective multicenter registry study enrolling patients with nonmetastatic UTUC undergoing URS followed by SI-MMC. Data will be compared to a historical control cohort without adjuvant MMC. Patients are aged ≥18 yr with no history of bladder cancer or contralateral UTUC. The study is following the principles of the Declaration of Helsinki and has received ethics approval. Primary and secondary outcomes: The primary outcome is total IVR and time to IVR. The secondary outcome is evaluation of predictive variables for IVR in patients with UTUC after endoscopic treatment. Discussion: Given the high recurrence rate after URS, the study aim is to provide evidence regarding MMC use to reduce IVR and address the current lack of robust data for this strategy. The study has potential to change clinical practice by demonstrating the efficacy of SI-MMC in preventing IVR after URS for UTUC.http://www.sciencedirect.com/science/article/pii/S2666168325001065Intravesical recurrenceMitomycin CUpper tract urothelial cancerUreteroscopy |
| spellingShingle | Orlane Figaroa Ranan Dasgupta Nora Hendriks Guido Kamphuis Jorg Oddens Jeroen van Moorselaar Adriaan Bins Joyce Baard Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study Intravesical recurrence Mitomycin C Upper tract urothelial cancer Ureteroscopy |
| title | Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study |
| title_full | Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study |
| title_fullStr | Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study |
| title_full_unstemmed | Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study |
| title_short | Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study |
| title_sort | effect of a single intravesical instillation of mitomycin c on the intravesical recurrence rate after ureteroscopy for upper tract urothelial carcinoma the sincere prospective multicenter registry study |
| topic | Intravesical recurrence Mitomycin C Upper tract urothelial cancer Ureteroscopy |
| url | http://www.sciencedirect.com/science/article/pii/S2666168325001065 |
| work_keys_str_mv | AT orlanefigaroa effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy AT ranandasgupta effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy AT norahendriks effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy AT guidokamphuis effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy AT jorgoddens effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy AT jeroenvanmoorselaar effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy AT adriaanbins effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy AT joycebaard effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy |
